AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Cronos Group Inc (NASDAQ:CRON)
2.77 USD
+0.030 1.095%Sponsored Reports
Loading...
| Previous Close (in USD) | 2.74 |
|---|---|
| Change | +0.030 1.095% |
| 52 W H/L (in USD) | 3.430/1.780 |
| EBITDA (in USD) | -3.353M |
| PE Ratio | -- |
| Volume | 1209664 |
| Diluted Eps TTM | -0.02 |
| Total Assets (in USD) | 1197.14M |
|---|---|
| Total Liabilities (in USD) | 54.181M |
| Revenue TTM (in USD) | 146.587M |
| Cash (in USD) | 791.794M |
| Market Cap (in USD) | 1,050.010 M |
| Revenue Per Share TTM | 0.382 |
| Gross Profit TTM (in USD) | 58.401M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
Employees: 610
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Michael Ryan Gorenstein J.D. | Pres, CEO & Chairman | 1987 |
| 2. | Ms. Shannon Buggy | Sr. VP & Global Head of People | 1970 |
| 3. | Ms. Anna Shlimak | Sr. VP of Corp. Affairs & Strategy | 1986 |
| 4. | Mr. James Holm | Chief Financial Officer | NA |
| 5. | Mr. Carlos Cortez | VP, Controller & Principal Accounting Officer | 1973 |
| 6. | Mr. Shayne J. Laidlaw | Director of Investor Relations & Strategy | NA |
| 7. | Mr. Terry Gregory-Joseph Doucet | Sr. VP of Legal & Regulatory Affairs and Corp. Sec. | 1990 |
| 8. | Mr. Jeffrey David Jacobson | Chief Growth Officer | 1986 |
| 9. | Mr. Arye Weigensberg | Head of R&D | NA |
| 10. | Mr. Kevin B Gifford | VP of Fin. | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
-0.620 0.781% | 79.56 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
+0.280 0.893% | 31.65 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
-4.068 2.484% | 159.71 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
GALDY
GALDERMA GROUP AG |
+1.190 2.942% | 41.08 | 74.210 | 41.667 | 8.636 | 5.553 | 9.151 | 42.220 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Income Before Tax | -17.12M | 36.586M | -73.669M | -134.559M | -397.135M |
| Minority Interest | -6.518M | 1.058M | 0.326M | 0M | -1.097M |
| Net Income | -9.447M | 41.08M | -73.963M | -168.734M | -396.704M |
| Selling General Administrative | 41.999M | 55.214M | 58.231M | 86.293M | 106.633M |
| Gross Profit | 62.759M | 25.198M | 11.909M | 11.969M | -17.534M |
| Reconciled Depreciation | 14.231M | 9.336M | 9.556M | 13.122M | 15.402M |
| Ebit | -17.12M | -59.549M | -79.91M | -116.012M | 6.785M |
| Ebitda | -15.001M | -50.213M | -71.8M | -59.185M | 22.187M |
| Depreciation And Amortization | 2.119M | 9.336M | 8.11M | 56.827M | 15.402M |
| Operating Income | -2.929M | -76.529M | -84.8M | -116.012M | 6.785M |
| Other Operating Expenses | 196.292M | 194.144M | 172.041M | 207.916M | 271.354M |
| Interest Expense | - | - | - | 22.537M | 0.027M |
| Tax Provision | -14.191M | -3.436M | 29.133M | 34.175M | -0.431M |
| Interest Income | 39.963M | 52.019M | 46.543M | 22.537M | 9.098M |
| Net Interest Income | 39.963M | 52.019M | 46.53M | 22.537M | 9.071M |
| Income Tax Expense | -7.673M | -3.436M | -3.23M | 34.175M | -0.431M |
| Total Revenue | 193.363M | 117.615M | 87.241M | 91.904M | 74.435M |
| Total Operating Expenses | 65.688M | 101.727M | 96.709M | 127.981M | 179.385M |
| Cost Of Revenue | 130.604M | 92.417M | 75.332M | 79.935M | 91.969M |
| Total Other Income Expense Net | -14.191M | 113.115M | 11.131M | -18.547M | -403.92M |
| Net Income From Continuing Ops | -2.929M | 40.022M | -115.025M | -168.734M | -396.704M |
| Net Income Applicable To Common Shares | - | - | - | -168.734M | -396.107M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Total Assets | 1197.14M | 1166.312M | 1134.252M | 1213.009M | 1397.738M |
| Intangible Assets | 8.89M | 11.129M | 21.078M | 26.704M | 18.079M |
| Other Current Assets | 8.344M | 14.389M | 5.377M | 7.106M | 8.967M |
| Total Liab | 54.181M | 55.33M | 43.736M | 72.045M | 63.462M |
| Total Stockholder Equity | 1093.897M | 1064.063M | 1093.945M | 1143.885M | 1337.243M |
| Other Current Liab | 36.21M | 19.862M | 28.066M | 55.623M | 14.375M |
| Common Stock | 661.776M | 669.879M | 610.585M | 611.318M | 595.497M |
| Capital Stock | 662.983M | 669.879M | 613.725M | 611.318M | 595.497M |
| Retained Earnings | 447.756M | 457.709M | 414.587M | 490.682M | 659.416M |
| Good Will | 66.478M | 63.453M | 1.052M | 1.033M | 1.098M |
| Other Assets | - | 0.128M | 0M | 72.538M | 80.735M |
| Cash | 791.794M | 858.805M | 665.867M | 764.644M | 886.973M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 48.187M | 49.7M | 41.187M | 68.116M | 54.373M |
| Current Deferred Revenue | - | - | 0.064M | - | 26.069M |
| Net Debt | -790.285M | -856.787M | -663.327M | -760.768M | -877.167M |
| Short Term Debt | 0.337M | 1.025M | 0.989M | 1.33M | 2.711M |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 1.509M | 2.018M | 2.54M | 3.876M | 9.806M |
| Other Stockholder Equity | 662.983M | 669.879M | 48.201M | 42.682M | 32.465M |
| Property Plant Equipment | - | - | - | 62.83M | 82.952M |
| Total Current Assets | 944.086M | 936.113M | 928.531M | 960.156M | 1079.718M |
| Long Term Investments | 7.664M | 2.813M | 54.739M | 89.748M | 135.156M |
| Short Term Investments | 40M | 0M | 191.253M | 113.077M | 117.684M |
| Net Receivables | 57.198M | 29.77M | 35.694M | 37.77M | 33.292M |
| Long Term Debt | - | - | - | - | - |
| Inventory | 46.75M | 33.149M | 30.339M | 37.559M | 32.802M |
| Accounts Payable | 11.64M | 16.973M | 12.068M | 11.163M | 11.218M |
| Accumulated Other Comprehensive Income | -16.842M | -63.525M | 20.572M | -0.797M | 49.865M |
| Non Currrent Assets Other | 20.847M | 15.526M | 0.045M | 72.538M | 0.1M |
| Non Current Assets Total | 253.054M | 230.071M | 205.721M | 252.853M | 318.02M |
| Capital Lease Obligations | 1.509M | 2.018M | 2.553M | 3.876M | 9.806M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Investments | -45.107M | 175.149M | 17.066M | -1.842M | -14.699M |
| Total Cashflows From Investing Activities | -77.899M | 175.149M | -59.499M | -1.842M | -28.898M |
| Total Cash From Financing Activities | -20.253M | -1.231M | -1.03M | -2.897M | -13.442M |
| Net Income | -9.447M | 40.022M | -74.553M | -168.734M | -397.204M |
| Change In Cash | -67.941M | 189.514M | -95.353M | -122.329M | -191.05M |
| Begin Period Cash Flow | 858.805M | 669.291M | 764.644M | 886.973M | 1078.023M |
| End Period Cash Flow | 791.794M | 858.805M | 669.291M | 764.644M | 886.973M |
| Total Cash From Operating Activities | 26.319M | 18.843M | -42.835M | -88.948M | -153.616M |
| Depreciation | 14.231M | 9.336M | 8.11M | 13.122M | 15.402M |
| Other Cashflows From Investing Activities | - | 8.41M | 18.415M | 0.452M | 1.652M |
| Dividends Paid | - | - | 0.345M | 0.384M | - |
| Change To Inventory | -10.577M | 5.284M | 7.399M | -7.217M | 11.565M |
| Sale Purchase Of Stock | -9.912M | 0M | -1.365M | - | - |
| Other Cashflows From Financing Activities | -10.342M | -1.231M | -1.03M | -2.513M | -13.442M |
| Capital Expenditures | 26.167M | 13.154M | 3.423M | 5.032M | 12.262M |
| Change In Working Capital | -35.016M | -0.311M | -26.468M | 20.663M | -2.005M |
| Other Non Cash Items | 61.335M | -38.904M | 41.307M | 30.886M | -2.179M |
| Free Cash Flow | 0.152M | 5.689M | -46.258M | -93.98M | -165.878M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | ETFMG Alternative Harvest ETF | 2 months ago | 3877484 |
| 2. | Global X Marijuana Life Sciences ETF | 2 months ago | 1254265 |
| 3. | DFA International Small Company I | 3 months ago | 709981 |
| 4. | DFA International Core Equity 2 I | 3 months ago | 677590 |
| 5. | iShares Core MSCI Total Intl Stk ETF | 2 months ago | 664585 |
| 6. | State St Gbl Sm Cp Eq ex-US Indx NL Cl A | 2 months ago | 580801 |
| 7. | Dimensional Canadian Small Company | 7 months ago | 577714 |
| 8. | AdvisorShares Pure Cannabis ETF | 2 months ago | 532394 |
| 9. | USA Mutuals Vice Investor | 5 months ago | 480000 |
| 10. | Dimensional International Small Cap ETF | 2 months ago | 448673 |
| 11. | DFA Canadian Core Equity Class F | 4 months ago | 367946 |
| 12. | State St Gbl AllCp Eq ex-US Idx SL Cl I | 6 months ago | 360438 |
| 13. | Dimensional International Core Eq 2 ETF | 2 months ago | 353702 |
| 14. | Cambria Cannabis ETF | 2 months ago | 336603 |
| 15. | iShares Core MSCI Intl Dev Mkts ETF | 2 months ago | 274969 |
| 16. | Acuitas US Microcap Strategy | 5 months ago | 258673 |
| 17. | Fidelity Nasdaq Composite Index | 3 months ago | 226947 |
| 18. | BlackRock MSCI ACWI ex-U.S. IMI Ind M | 2 months ago | 217811 |
| 19. | DFA International Vector Equity I | 3 months ago | 203179 |
| 20. | CANSOUL Fonds Hanf Aktien Global EUR C | 3 months ago | 200000 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | D. E. Shaw & Co LP | 5 months ago | 6859438 |
| 2. | Tidal Investments LLC. | 5 months ago | 4143004 |
| 3. | Mmcap International Inc. Spc | 5 months ago | 2761059 |
| 4. | Dimensional Fund Advisors, Inc. | 5 months ago | 2506210 |
| 5. | Royal Bank of Canada | 8 months ago | 1936387 |
| 6. | Arrowstreet Capital Limited Partnership | 5 months ago | 1878976 |
| 7. | Renaissance Technologies Corp | 5 months ago | 1845049 |
| 8. | Pillsbury Lake Capital LLC | 5 months ago | 1839003 |
| 9. | Citadel Advisors Llc | 5 months ago | 1768701 |
| 10. | Jane Street Group LLC | 5 months ago | 1345105 |
| 11. | Two Sigma Investments LLC | 5 months ago | 1124234 |
| 12. | Susquehanna International Group, LLP | 5 months ago | 1075731 |
| 13. | Chescapmanager LLC | 5 months ago | 7942737 |
| 14. | Hillsdale Investment Management Inc. | 5 months ago | 997180 |
| 15. | Quinn Opportunity Partners LLC | 5 months ago | 969033 |
| 16. | CDC Financial, Inc. | 5 months ago | 946832 |
| 17. | Oasis Management Co. Ltd | 5 months ago | 915867 |
| 18. | Qube Research & Technologies | 5 months ago | 822044 |
| 19. | SIMPLEX TRADING, LLC | 5 months ago | 781566 |
| 20. | Silver OAK Securities, INC. | 5 months ago | 620432 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...